![Jeffrey Humphrey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeffrey Humphrey
Plus aucun poste en cours
Profil
Jeffrey S.
Humphrey served as an Independent Director at Cyteir Therapeutics, Inc. from 2021 to 2023.
Prior to that, he was the Senior Vice President-Drug Development at Kyowa Hakko Kirin Pharma, Inc. from 2012 to 2013.
He also held the position of Chief Medical Officer at Constellation Pharmaceuticals, Inc. from 2020 to 2021 and Chief Development Officer at Kyowa Kirin Co., Ltd. from 2019 to 2020.
From 2013 to 2019, he served as the President & Chief Medical Officer at Kyowa Kirin Pharmaceutical Development Ltd. In addition, he was the Chief Medical Officer at Magenta Therapeutics, Inc. from 2021 to 2022 and will be the Chief Medical Officer at Lantheus Holdings, Inc. from 2024 to 2025.
Dr. Humphrey obtained his undergraduate degree from Harvard College and his doctorate from Case Western Reserve University School of Medicine.
Anciens postes connus de Jeffrey Humphrey
| Sociétés | Poste | Fin |
|---|---|---|
| LANTHEUS HOLDINGS, INC. | Directeur Technique/Scientifique/R&D | 03/01/2025 |
| CYTEIR THERAPEUTICS, INC. | Directeur/Membre du Conseil | 29/11/2023 |
| MAGENTA THERAPEUTICS | Directeur Technique/Scientifique/R&D | 01/08/2022 |
| CONSTELLATION PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 15/07/2021 |
| KYOWA KIRIN CO., LTD. | Corporate Officer/Principal | 01/06/2020 |
Formation de Jeffrey Humphrey
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
34
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Kyowa Hakko Kirin Pharma, Inc. | |
Constellation Pharmaceuticals, Inc.
 Constellation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs targeting regulators of epigenetic function | Health Technology |
Kyowa Kirin Co., Ltd.
 Kyowa Kirin Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals; develops biochemical reagents and other chemicals | Health Technology |
Kyowa Kirin Pharmaceutical Development Ltd.
 Kyowa Kirin Pharmaceutical Development Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in developing pharmaceutical products | Commercial Services |
Lantheus Holdings, Inc.
 Lantheus Holdings, Inc. Medical SpecialtiesHealth Technology Manufactures, markets, sells and distributes medical imaging products | Health Technology |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Case Western Reserve University School of Medicine
 Case Western Reserve University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cyteir Therapeutics, Inc.
 Cyteir Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage oncology company | Health Technology |
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines | Health Technology |
